The Short Form-36: Pre- Versus Post-Surgical Administration in Cardiac Surgery Patients
Study Details
Study Description
Brief Summary
The purpose of this study is to determine whether the SF-36 can be administered reliably to cardiac surgery patients (two to three days) post-surgery, with the patient answering the questions of this survey from a pre-surgical perspective.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
The purpose of this study, is to determine whether the SF-36 can be administered reliably to cardiac surgery patients (two to three days) post-surgery, with the patient answering the questions of this survey from a pre-surgical perspective.
Study Design
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Cardiac surgery patients who are between the ages of 18 and 100
-
Are English speaking
-
Able to give consent
-
Undergoing cardiac surgery including (but not limited to):
-
Aortic valve replacement (AVR)
-
Mitral valve replacement (MVR)
-
Tricuspid valve replacement (TVR)
-
Coronary artery bypass graft (CABG).
Exclusion Criteria:
- Non-cardiac surgery patients
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | The New York Presbyterian Hospital-Weill Medical Center | New York | New York | United States | 10021 |
Sponsors and Collaborators
- Weill Medical College of Cornell University
Investigators
- Principal Investigator: Mary E Charlson, MD, Weill Medical College of Cornell University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 1203-069